null
null
OncologyStat
®
One Source, Many Resources.
®
By Elsevier
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
DRUGS AND REGIMENS
Back to Results >
dictionary_preferred_regimen
Irinotecan, cisplatin (SCLC)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
This Regimen Is Used for:
Extensive disease therapy
Regimen Details
MEMBER LOG IN
Email Address
Password
Forgot your password?
Remember me
NOT A MEMBER?
Registration is FREE
Up-to-date oncology news
Journal article summaries
Commentaries and interviews
Drug and interactions database
Chemotherapy regimens
Daily e-newsletters
Comment
Print page
Share page
RSS feeds
Follow OncologySTAT on Twitter
Look for news reports from ASCO and other major conferences, journal scans, and more.
Start following ›
Categories
News
Journal Scans
Expert Opinion
Drugs and Regimens
Conferences
CME
Videos
Supportive Care
Skeletal-Related Events
Complications, GI and Oral
Hematologic Support
Infectious Complications
Neurologic Complications
Pain
Vascular Complications
Cancer Type
Bladder
Bone
Breast
Breast (ER-Positive)
CNS/Brain
Colon and Rectum
Endocrine System
Esophagus
GYN (Non-Ovary)
GYN (Ovary)
Head and Neck
Hodgkin's Lymphoma
Kidney (Renal Cell)
Leukemia
Liver and Bile Duct
Lung
Multiple Myeloma
Myelodysplastic Syndrome
Myeloproliferative Diseases
Non-Hodgkin's Lymphoma
Pancreas
Pediatric Cancers
Prostate
Rare Cancers
Skin
Soft-Tissue Sarcoma
Stomach
Testicle
Lung/
General
none
none
none
n
Advanced Search
Email Address
Password
Remember Me
Forgot your password?
Not a member?
Free registration
Elsevier
Home
Site Map
Cancer Types
About OncologySTAT
Privacy Policy
Terms of Use
Contact Us
Advertise
Copyright © 2012
Elsevier Inc.
All rights reserved.